Literature DB >> 3908684

Marcella O'Grady Boveri (1865-1950) and the chromosome theory of cancer.

V A McKusick.   

Abstract

Born into a Boston Irish family, Marcella Imelda O'Grady was the first woman graduate in biology from MIT (1885) where she came under the influence of two recent PhD graduates of Johns Hopkins University, William Townsend Sedgwick and Edmund Beecher Wilson. She taught science at Bryn Mawr School for girls in Baltimore 1885 to 1887 and was teaching assistant with E B Wilson at Bryn Mawr College for women in Bryn Mawr, Pennsylvania, 1887 to 1889. From 1889 to 1896 she headed the Department of Biology at Vassar College for women in Poughkeepsie, New York. On the recommendation of E B Wilson (who from the first edition in 1896 dedicated his famous book The cell in development and inheritance to Boveri) Marcella went to Würzburg to spend a sabbatical with Boveri. One year later she married Boveri and during the next 18 years until Boveri's untimely death in 1915 she was her husband's close scientific collaborator, especially in his work at the marine zoological stations in Naples and Villefranche, France. She also acquired (from Freiburg) the doctorate she had unsuccessfully attempted to get at Johns Hopkins. Marcella returned to the United States in 1926 and headed the Biology Department at Albertus Magnus College in New Haven. She was there in 1929 when her English translation of her husband's 1914 monograph advancing the chromosome theory of cancer was published. The translation did much to bring that theory to the attention of a wider audience which has thereby been able to rediscover Boveri, despite lack of a reading knowledge of German. Boveri's theory was based on the views that cancer is a cellular problem, cancers originate from a single cell, this cell has an abnormality of its chromosomal constitution, and the chromosomal abnormality which is passed on to all the descendants of the cell of origin is the cause of rapid cell proliferation.

Entities:  

Mesh:

Year:  1985        PMID: 3908684      PMCID: PMC1049502          DOI: 10.1136/jmg.22.6.431

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  CYTOGENETIC EVIDENCE OF CLONAL PROLIFERATION IN PRIMARY RETICULAR NEOPLASMS.

Authors:  C E FORD; C M CLARKE
Journal:  Proc Can Cancer Conf       Date:  1963

2.  An attack on cytologism.

Authors:  D W SMITHERS
Journal:  Lancet       Date:  1962-03-10       Impact factor: 79.321

3.  THEODOR BOVERI.

Authors:  R Goldschmidt
Journal:  Science       Date:  1916-02-25       Impact factor: 47.728

4.  Clonal origin of chronic myelocytic leukemia in man.

Authors:  P J Fialkow; S M Gartler; A Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

5.  Is somatic mutation the major mechanism of malignant transformation?

Authors:  H Rubin
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

  5 in total
  4 in total

1.  Oncogenetics. A new emerging field of cancer.

Authors:  R S Verma
Journal:  Mol Gen Genet       Date:  1986-12

Review 2.  Centrosome - a promising anti-cancer target.

Authors:  Yainyrette Rivera-Rivera; Harold I Saavedra
Journal:  Biologics       Date:  2016-12-13

3.  Addressing Drug Resistance in Cancer: A Team Medicine Approach.

Authors:  Prakash Kulkarni; Atish Mohanty; Supriyo Bhattacharya; Sharad Singhal; Linlin Guo; Sravani Ramisetty; Tamara Mirzapoiazova; Bolot Mambetsariev; Sandeep Mittan; Jyoti Malhotra; Naveen Gupta; Pauline Kim; Razmig Babikian; Swapnil Rajurkar; Shanmuga Subbiah; Tingting Tan; Danny Nguyen; Amartej Merla; Sudarsan V Kollimuttathuillam; Tanyanika Phillips; Peter Baik; Bradford Tan; Pankaj Vashi; Sagun Shrestha; Benjamin Leach; Ruchi Garg; Patricia L Rich; F Marc Stewart; Evan Pisick; Ravi Salgia
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

Review 4.  Cancer prevention and screening: the next step in the era of precision medicine.

Authors:  Holli A Loomans-Kropp; Asad Umar
Journal:  NPJ Precis Oncol       Date:  2019-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.